Stock listing
OTC:ZIVO Zivo Bioscience, Inc. Stock
Follow Zivo Bioscience, Inc. into a list and get an email when it puts out news.
Share price · OTC:ZIVO
$5.50 USD 0.00 (0.0%)
Close on Nov 20, 2026
- Day range
- $5.50 – $5.50 USDNov 20, 2026
- Volume
- 100 sharesNov 20, 2026
- Market cap
- $23.18M USDAt the close on Nov 20, 2026 · price × 4.22M shares outstanding
- 52-week range
- $1.11 – $12.04 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2,746 USDMedian day 200 shares · 21 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ZIVO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.50 | 0.00 | 0.0% | $5.50 | $5.50 | $5.50 | 100 | |
| $5.50 | 0.00 | 0.0% | $5.25 | $5.50 | $5.25 | 529 | |
| $5.50 | -0.25 | -4.3% | $5.85 | $5.99 | $5.50 | 337 | |
| $5.75 | -0.25 | -4.2% | $5.75 | $5.75 | $5.75 | 13 | |
| $6.00 | -1.25 | -17.2% | $5.76 | $6.00 | $5.76 | 50 | |
| $7.25 | -0.75 | -9.4% | $8.12 | $8.12 | $7.25 | 35 | |
| $8.00 | +0.75 | +10.3% | $10.49 | $10.49 | $8.00 | 30 | |
| $7.25 | -0.87 | -10.7% | $7.25 | $7.25 | $7.25 | 134 | |
| $8.12 | -0.47 | -5.5% | $8.12 | $8.12 | $8.12 | 200 | |
| $8.59 | +1.34 | +18.5% | $9.24 | $9.24 | $8.27 | 2,100 | |
| $7.25 | +1.00 | +16.0% | $7.00 | $7.25 | $7.00 | 400 | |
| $6.25 | 0.00 | 0.0% | $6.25 | $6.25 | $6.25 | 0 | |
| $6.25 | 0.00 | 0.0% | $6.25 | $6.25 | $6.25 | 0 | |
| $6.25 | +0.10 | +1.6% | $6.25 | $6.25 | $6.25 | 200 | |
| $6.15 | -0.65 | -9.6% | $6.23 | $6.23 | $6.15 | 1,000 | |
| $6.80 | 0.00 | 0.0% | $6.80 | $6.80 | $6.80 | 0 | |
| $6.80 | 0.00 | 0.0% | $6.80 | $6.80 | $6.80 | 0 | |
| $6.80 | +0.30 | +4.6% | $6.50 | $6.80 | $6.50 | 1,000 | |
| $6.50 | -0.01 | -0.2% | $6.91 | $6.91 | $6.50 | 1,900 | |
| $6.51 | 0.00 | 0.0% | $6.51 | $6.51 | $6.51 | 9 | |
| $6.51 | 0.00 | 0.0% | $6.51 | $6.51 | $6.51 | 0 | |
| $6.51 | +1.21 | +22.8% | $6.19 | $6.51 | $6.19 | 1,900 | |
| $5.30 | 0.00 | 0.0% | $5.30 | $5.30 | $5.30 | 0 | |
| $5.30 | +1.06 | +25.0% | $4.40 | $5.31 | $4.40 | 3,900 | |
| $4.24 | +0.14 | +3.4% | $4.19 | $4.30 | $4.19 | 400 | |
| $4.10 | 0.00 | 0.0% | $4.10 | $4.10 | $4.10 | 200 | |
| $4.10 | 0.00 | 0.0% | $4.10 | $4.10 | $4.10 | 0 | |
| $4.10 | +0.09 | +2.2% | $3.94 | $4.15 | $3.94 | 1,700 | |
| $4.01 | +0.47 | +13.3% | $3.60 | $4.01 | $3.60 | 1,100 | |
| $3.54 | +0.24 | +7.3% | $3.35 | $3.55 | $3.35 | 1,600 | |
| $3.30 | 0.00 | 0.0% | $3.30 | $3.30 | $3.30 | 0 | |
| $3.30 | 0.00 | 0.0% | $3.30 | $3.30 | $3.30 | 0 | |
| $3.30 | 0.00 | 0.0% | $3.30 | $3.30 | $3.30 | 0 | |
| $3.30 | -0.30 | -8.3% | $3.51 | $3.51 | $3.30 | 400 | |
| $3.60 | 0.00 | 0.0% | $3.60 | $3.60 | $3.60 | 0 | |
| $3.60 | +0.05 | +1.4% | $3.80 | $3.80 | $3.51 | 2,000 | |
| $3.55 | +0.35 | +10.9% | $3.25 | $3.55 | $3.25 | 900 | |
| $3.20 | 0.00 | 0.0% | $3.20 | $3.20 | $3.20 | 200 | |
| $3.20 | +0.01 | +0.3% | $3.20 | $3.20 | $3.20 | 200 | |
| $3.19 | -0.16 | -4.8% | $3.35 | $3.35 | $3.19 | 600 | |
| $3.35 | -0.75 | -18.3% | $4.00 | $4.00 | $3.35 | 1,900 | |
| $4.10 | 0.00 | 0.0% | $4.10 | $4.10 | $4.10 | 0 | |
| $4.10 | 0.00 | 0.0% | $4.10 | $4.10 | $4.10 | 1 | |
| $4.10 | +0.50 | +13.9% | $3.80 | $4.15 | $3.80 | 1,700 | |
| $3.60 | +0.49 | +15.8% | $3.33 | $3.60 | $3.33 | 500 | |
| $3.11 | 0.00 | 0.0% | $3.11 | $3.11 | $3.11 | 0 | |
| $3.11 | -0.49 | -13.6% | $3.50 | $3.50 | $3.01 | 800 | |
| $3.60 | 0.00 | 0.0% | $3.60 | $3.60 | $3.60 | 0 | |
| $3.60 | -0.35 | -8.9% | $3.95 | $3.95 | $3.60 | 1,700 | |
| $3.95 | 0.00 | 0.0% | $3.95 | $3.95 | $3.95 | 0 | |
| $3.95 | -0.32 | -7.5% | $3.96 | $3.96 | $3.95 | 300 | |
| $4.27 | 0.00 | 0.0% | $4.27 | $4.27 | $4.27 | 0 | |
| $4.27 | 0.00 | 0.0% | $4.27 | $4.27 | $4.27 | 0 | |
| $4.27 | 0.00 | 0.0% | $4.27 | $4.27 | $4.27 | 0 | |
| $4.27 | 0.00 | 0.0% | $4.27 | $4.27 | $4.27 | 0 | |
| $4.27 | 0.00 | 0.0% | $4.27 | $4.27 | $4.27 | 0 | |
| $4.27 | +0.02 | +0.5% | $4.32 | $4.33 | $4.27 | 2,700 | |
| $4.25 | +0.30 | +7.6% | $4.30 | $4.30 | $4.25 | 400 | |
| $3.95 | 0.00 | 0.0% | $3.95 | $3.95 | $3.95 | 0 |
Splits
1 split · OTC:ZIVO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-6 | Consolidation |
- Ticker
- OTC:ZIVO
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Zivo Bioscience, Inc. on 6ix
- Decks
- 10 decks · latest January 2025
Valuation
balance Sep 30, 2025 · price Nov 20, 2026
- Enterprise value
- $23.13M USD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.67
Forecasts
1 hold · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.00 USD · Analysts' mean
- EPS, year to Dec 2025
- -2.10 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| John B. Payne | President / Chief Executive Officer / Chairman of the Board |
| Amy Steffek | Director, Research & Development |
Board
| Director | Role |
|---|---|
| John B. Payne | President / Chief Executive Officer / Chairman of the Board |
| Christopher Maggiore | Director since 2013 |
| Laith Yaldoo | Director since 2024 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Jun 30, 2026 | Sep 2, 2026 | −8.9% |
| Quarter to Mar 31, 2026 | Jun 3, 2026 | −15.4% |
| Quarter to Dec 31, 2025 | Feb 25, 2026 | −2.6% |
| Q3 2025 | Nov 14, 2025 · After close | −2.9% |
| Q2 2025 | Aug 14, 2025 · After close | +0.2% |
| Q1 2025 | May 15, 2025 · After close | 0.0% |
| Q4 2024 | Mar 13, 2025 · After close | 0.0% |
| Q3 2024 | Nov 14, 2024 · After close | −0.2% |
| Q2 2024 | Aug 14, 2024 · After close | −20.8% |
| Q1 2024 | May 13, 2024 · After close | 0.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 28, 2024 | −6.9% |
| Q3 2023 | Nov 13, 2023 · After close | −3.5% |
| Q2 2023 | Aug 14, 2023 · After close | −3.2% |
| Q1 2023 | May 10, 2023 · After close | −2.2% |
| Q4 2022 | Mar 14, 2023 · After close | −6.7% |
| Q3 2022 | Nov 14, 2022 · After close | −1.4% |
| Q2 2022 | Aug 4, 2022 · After close | 0.0% |
| Q1 2022 | May 13, 2022 · After close | −2.3% |
| Q4 2021 | Mar 2, 2022 | +1.7% |
| Q3 2021 | Nov 15, 2021 · After close | −4.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| January 2025 Microcap Conference | Conference | 17 slides | January 2025 |
| Investor Presentation (August 2024) | Investor deck | 15 slides | August 2024 |
| Dawon James Small Cap Growth Conference (October 2023) | Conference | 13 slides | October 2023 |
| Investor Presentation (January 2023) | Investor deck | 10 slides | January 2023 |
| Shareholder Meeting (October 2021) | Shareholder meeting | 23 slides | Oct 12, 2021 |
| Non-Deal Roadshow (June 2021) | Roadshow | 24 slides | June 2021 |
| Investor Presentation (March 2021) | Investor deck | 17 slides | Mar 17, 2021 |
| Corporate Update (April 2020) | Corporate update | 27 slides | April 2020 |
| Shareholder Meeting (May 2019) | Shareholder meeting | 44 slides | May 1, 2019 |
| Biotech Showcase 2018 | Conference | 24 slides | Jan 10, 2018 |
Financials
Annual, in USD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 157.2K | 27.6K | 0 | 0 | 20.0K | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 108.3K | 16.0K | 0 | |||||||
| Gross profit | 49.0K | 11.6K | 0 | |||||||
| Research and development | 3.13M | 1.38M | 2.24M | 1.95M | 3.75M | 2.31M | 2.81M | 2.38M | 789.0K | 1.03M |
| Operating income | -13.4M | -7.26M | -8.73M | -8.65M | -8.56M | -8.35M | -6.13M | -6.33M | -3.49M | -3.06M |
| Depreciation and amortization | 0 | 0 | 0 | 0 | 18.8K | 25.0K | 25.0K | |||
| EBITDA | -8.65M | -8.56M | -8.35M | -6.13M | -6.31M | -3.47M | -3.03M | |||
| Interest expense | 23.8K | 13.3K | 44.7K | 97.6K | -35.5K | -2.40K | ||||
| Net income | -13.4M | -7.78M | -8.75M | -8.76M | -9.11M | -11.5M | -14.6M | -10.0M | -6.06M | -5.79M |
| Earnings per share, basic | -3.70 | -3.26 | -5.57 | -0.93 | -0.02 | -0.04 | -0.09 | -0.07 | -0.05 | -0.04 |
| Earnings per share, diluted | -4.23 | -4.60 | -0.02 | -0.04 | -0.09 | -0.07 | -0.05 | -0.04 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.54M | 274.4K | 1.80M | 8.90M | 137.9K | 346.1K | 388.9K | 317.1K | 507.0K | 16.6K |
| Receivables | 0 | |||||||||
| Current assets | 1.64M | 425.4K | 1.90M | 8.96M | 167.8K | 369.4K | 411.5K | 332.3K | 520.4K | 28.9K |
| Property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.8K | 43.8K | |
| Total assets | 1.64M | 555.7K | 2.12M | 8.99M | 220.2K | 369.4K | 411.5K | 332.3K | 737.3K | 72.7K |
| Accounts payable | 547.1K | 993.1K | 490.7K | 654.3K | 1.56M | 1.37M | 422.4K | 541.7K | 666.4K | 1.11M |
| Current liabilities | 2.04M | 2.76M | 2.03M | 2.95M | 11.4M | 8.71M | 22.7M | 4.56M | 11.2M | 4.97M |
| Total debt | 0 | 0 | 105.9K | 0 | ||||||
| Total liabilities | 2.16M | 2.76M | 2.13M | 2.95M | 11.5M | 8.71M | 22.7M | 16.6M | 14.4M | 9.57M |
| Shareholders' equity | -514.9K | -2.21M | -10.6K | 6.04M | -11.3M | -8.34M | -22.3M | -16.3M | -13.6M | -9.50M |
| Shares outstanding | 3.62M | 2.38M | 1.57M | 9.42M | 5.16M | 413.0M | 180.0M | 141.1M | 136.7M | 132.2M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4.31M | -5.80M | -7.10M | -6.80M | -2.59M | -3.71M | -5.01M | -4.24M | -2.54M | -2.30M |
| Cash from investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from financing | 5.58M | 4.28M | 0 | 15.6M | 2.38M | 3.66M | 5.08M | 4.05M | 3.03M | 2.31M |
| Change in cash | 1.27M | -1.52M | -7.10M | 8.76M | -208.2K | 490.4K | 15.2K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Apr 24, 2026 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Apr 2, 2026 | Other filings | SEC |
| 15-12G | Mar 30, 2026 | Other filings | SEC |
| S-8 POS | Mar 30, 2026 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Mar 30, 2026 | Offer document | SEC |
| 8-K · Current report | Mar 30, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Feb 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 12, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 27, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 29, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 23, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 10, 2025 | Current report | SEC |
| 8-K · Current report | Aug 18, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 14, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jun 16, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 11, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 25, 2025 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 25, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| 10-K · Annual report | Mar 18, 2025 | Annual report | SEC |
| 8-K · Current report | Jan 27, 2025 | Financing | SEC |
| 5 · Annual statement of ownership | Jan 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 15, 2025 | Material contract | SEC |
| 8-K · Current report | Jan 7, 2025 | Current report | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 31, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 15, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 18, 2024 | Financing | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 1, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Oct 1, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 23, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 30, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 17, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 13, 2024 | Meeting outcome | SEC |
| SC 13D · Big-stake notice | Jun 12, 2024 | Big-stake notice | SEC |
| SC 13D · Big-stake notice | Jun 12, 2024 | Big-stake notice | SEC |
| SC 13D · Big-stake notice | Jun 12, 2024 | Big-stake notice | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 7, 2024 | Big-stake notice | SEC |
| 8-K/A · Current report, amended | Jun 7, 2024 | Material contract | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 6, 2024 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Jun 5, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2024 | Insider trade | SEC |
| CORRESP · Letter to the SEC | May 31, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | May 13, 2024 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | May 3, 2024 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 26, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 26, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 26, 2024 | Meeting notice | SEC |
| SC 13D/A · Big-stake notice, amended | Apr 9, 2024 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 15, 2024 | Annual report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 14, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 15, 2024 | Current report | SEC |
| 25-NSE | Feb 15, 2024 | Other filings | SEC |
| SC 13D · Big-stake notice | Jan 22, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 17, 2024 | Financing | SEC |
| 8-K · Current report | Jan 5, 2024 | Financing | SEC |
| 4 · Change in ownership | Jan 4, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 3, 2024 | Financing | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 11, 2023 | Financing | SEC |
| RW · Request to withdraw a registration | Dec 1, 2023 | Other filings | SEC |
| 8-K · Current report | Nov 27, 2023 | Current report | SEC |
| 8-K · Current report | Nov 22, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| S-1/A · Registration statement, amended | Nov 3, 2023 | Offer document | SEC |
| S-1/A · Registration statement, amended | Oct 31, 2023 | Offer document | SEC |
| 4 · Change in ownership | Oct 30, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Oct 30, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Oct 26, 2023 | Current report | SEC |
| S-1 · Registration statement | Oct 4, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 9, 2023 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Aug 4, 2023 | Other filings | SEC |
| 424B3 · Prospectus | Aug 3, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Aug 1, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 31, 2023 | Other filings | SEC |
| S-3 · Registration statement | Jul 27, 2023 | Offer document | SEC |
| D | Jul 17, 2023 | Other filings | SEC |
| 8-K · Current report | Jul 6, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Jul 5, 2023 | Offer document | SEC |
| RW · Request to withdraw a registration | Jun 28, 2023 | Other filings | SEC |
| 8-K · Current report | Jun 15, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 14, 2023 | Insider trade | SEC |
| 8-K · Current report | May 26, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 10, 2023 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 28, 2023 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 28, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 5, 2023 | Insider trade | SEC |
| 8-K · Current report | Apr 5, 2023 | Material contract | SEC |
| S-1 · Registration statement | Mar 22, 2023 | Offer document | SEC |
| 10-K · Annual report | Mar 14, 2023 | Annual report | SEC |
| 4/A · Change in ownership, amended | Feb 14, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 10, 2023 | Current report | SEC |
| 4 · Change in ownership | Dec 21, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 21, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 20, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2022 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 8, 2022 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 8, 2022 | Insider trade | SEC |
| 8-K · Current report | Nov 29, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Sep 19, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 31, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 23, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Aug 4, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 3, 2022 | Meeting outcome | SEC |
| 4 · Change in ownership | Aug 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 1, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 1, 2022 | Insider trade | SEC |
| 8-K · Current report | Jul 7, 2022 | Current report | SEC |
| DEF 14A · Proxy statement | Jul 5, 2022 | Meeting notice | SEC |
| 8-K · Current report | Jun 28, 2022 | Current report | SEC |
| S-8 · Registration statement for employee plans | Jun 22, 2022 | Offer document | SEC |
| 8-K · Current report | May 20, 2022 | Current report | SEC |
| 10-Q · Quarterly report | May 13, 2022 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | May 2, 2022 | Annual report | SEC |
| 8-K · Current report | Apr 25, 2022 | Current report | SEC |
| 10-K · Annual report | Apr 22, 2022 | Annual report | SEC |
| 10-Q/A · Quarterly report, amended | Apr 20, 2022 | Quarterly report | SEC |
| 8-K · Current report | Apr 15, 2022 | Current report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2022 | Explanation request | SEC |
| 8-K/A · Current report, amended | Mar 1, 2022 | Management or board change | SEC |
| 8-K · Current report | Feb 25, 2022 | Management or board change | SEC |
| 8-K · Current report | Feb 16, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Feb 16, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 8-K · Current report | Jan 10, 2022 | Management or board change | SEC |
| 8-K/A · Current report, amended | Dec 9, 2021 | Current report | SEC |
| 8-K · Current report | Dec 9, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 15, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 15, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 15, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 15, 2021 | Insider trade | SEC |
| 8-K · Current report | Oct 14, 2021 | Meeting outcome | SEC |
| 8-K · Current report | Oct 12, 2021 | Current report | SEC |
| 4/A · Change in ownership, amended | Sep 28, 2021 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Sep 22, 2021 | Meeting notice | SEC |
| 8-K · Current report | Sep 21, 2021 | Management or board change | SEC |
| 8-K/A · Current report, amended | Sep 16, 2021 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Sep 13, 2021 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Sep 7, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 1, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 31, 2021 | Other filings | SEC |
| S-3 · Registration statement | Aug 26, 2021 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 16, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Jun 4, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2021 | Insider trade | SEC |
| 8-K · Current report | Jun 2, 2021 | Material contract | SEC |
| 424B4 · Prospectus | Jun 1, 2021 | Offer document | SEC |
This page holds 200 of 757 filings. Open Filings
Cap table
Built by 6ix from Zivo Bioscience, Inc.’s releases
- Common shares
- 4,215,112
- Fully diluted
- 4,215,112
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 4,215,112 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 4,215,112 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alison A Cornell Other companies: International Flavors & Fragrances, Inc. (EVP & CFO · May 2, 2016 – May 2, 2016 · Past) | Director · Since at least Feb 8, 2021 |
| John B. Payne Other companies: Nexvet Biopharma plc (Director · Feb 4, 2015 – Jul 31, 2017 · Past) | President / Chief Executive Officer / Chairman of the Board · Since at least Jul 19, 2013 |
| John D Crissman Other companies: Caraco Pharmaceutical Laboratories Ltd (Director · Jul 20, 2006 – Jul 20, 2009 · Past) | Director · Oct 13, 2010 – Jul 1, 2011 · Past |
| Amy Steffek | Director, Research & Development · Since at least Nov 5, 2026 |
| Andrew A Dahl | President / CEO, Director · Dec 16, 2011 – Oct 21, 2021 · Past |
| Christopher Maggiore | Director · Since at least Dec 13, 2023 |
| Keith Marchiando | Chief Financial Officer · Jan 1, 2021 – Jun 5, 2024 · Past |
| Laith Yaldoo | Director since 2024 · Since at least Jul 11, 2024 |
| Nola E Masterson | Director · Jun 5, 2024 – Jan 1, 2025 · Past |
| Philip M Rice II | Chief Financial Officer · Nov 4, 2011 – Apr 8, 2020 · Past |
All 11 people
| Person | Seat |
|---|---|
| William A Sullivan | Chief Financial Officer · Since at least Dec 19, 2025 |
Log in to ask 6ix AI your own questions about Zivo Bioscience, Inc.